Total Nutraceutical Solutions Receives Approval and Makes Initial Shipment

Total Nutraceutical Solutions, Inc. (TNS), announced today that it has received approval for importation of ImmuSANO(TM) and GlucoSANO(TM) from the Inspectorate of Public Health, Bureau of Pharmaceutical Affairs in Curacao, The Netherlands Antilles. Caribbean International Medical N.V. ("CIM"), based in Curacao, is the exclusive distributor for The Netherlands Antilles, Aruba, Trinadad-Tabago and Suriname with the option to expand to other Caribbean islands based on certain commercial benchmarks. The initial 1,000 unit shipment to CIM was sent on Thursday October 29th.

"CIM is an experienced sales and marketing company throughout the Caribbean," stated Marvin S. Hausman MD, CEO. "We are very happy to have CIM as a partner to handle the marketing, sales and distribution of our products in this geographic area."

"I am very excited that our company has partnered with TNS and we will utilize all of our expertise to commercialize the unique TNS product line throughout the Caribbean," stated Lloyd Philbert, CEO of CIM.

About Total Nutraceutical Solutions, Inc.:

Total Nutraceutical Solutions, Inc. (TNS), is an emerging nutraceutical company with a focus on discovering, formulating and marketing products composed primarily of organic natural mushroom compounds that contain bioactive nutrients for potential health benefits. TNS develops production and analytic technologies for food and nutritional supplements composed primarily of mushrooms and their mycelial biomasses. Novel clinical models and biomarkers are used to show nutritional and clinical efficacy of our products. In addition to preventative healthcare formulations and nutritional approaches to a wide variety of human conditions and illnesses, TNS also develops and acquires breakthrough nutritional tools and products in the fields of animal husbandry and livestock feeds.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Total Nutraceutical Solutions (TNS), Inc., with the Securities and Exchange Commission. Further information on risks faced by TNS are detailed in the Form 10-K for the year ended December 31, 2008, and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. TNS does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.